{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/chlamydia-uncomplicated-genital/diagnosis/signs-symptoms/","result":{"pageContext":{"chapter":{"id":"9da777e0-887a-5bb6-af7a-f6f0b986dbf4","slug":"signs-symptoms","fullItemName":"Signs and symptoms","depth":2,"htmlHeader":"<!-- begin field d1b7f47c-4a52-4491-b9bc-ec0500c941a5 --><h2>When should I suspect and test for chlamydia?</h2><!-- end field d1b7f47c-4a52-4491-b9bc-ec0500c941a5 -->","summary":"","htmlStringContent":"<!-- begin item 237a31b7-9ba9-4fbb-a2db-11702a034f2a --><!-- begin field b2ac0e73-28ab-404b-b29a-2651f65f1d7b --><ul><li><strong>Be aware that chlamydia is asymptomatic in around 70% of women and 50% of men, and that symptoms in men can be very mild.</strong></li><li><strong>Suspect chlamydia in sexually active women with:</strong><ul><li>Increased vaginal discharge.</li><li>Post-coital or intermenstrual bleeding.</li><li>Purulent vaginal discharge.</li><li>Mucopurulent cervical discharge.</li><li>Deep dyspareunia.</li><li>Dysuria.</li><li>Pelvic pain and tenderness.</li><li>Cervical motion tenderness.</li><li>Inflamed or friable cervix (which may bleed on contact).</li></ul></li><li><strong>Suspect chlamydia in sexually active men with:</strong><ul><li>Dysuria.</li><li>Mucoid or mucopurulent urethral discharge.</li><li>Urethral discomfort/urethritis.</li><li>Epididymo-orchitis.</li><li>Reactive arthritis.</li></ul></li><li><strong>Symptoms of rectal chlamydia</strong> include anal discharge and anorectal discomfort, although rectal infection is usually asymptomatic.</li><li><strong>Symptoms of lymphogranuloma venereum (LGV) include:</strong><ul><li>Tenesmus.</li><li>Anorectal discharge (often bloody) and discomfort.</li><li>Diarrhoea or altered bowel habit.</li></ul></li></ul><!-- end field b2ac0e73-28ab-404b-b29a-2651f65f1d7b --><!-- end item 237a31b7-9ba9-4fbb-a2db-11702a034f2a -->","topic":{"id":"9fd72b23-86c9-5ce5-bbdd-598398d0e8ea","topicId":"7ce33f6f-747f-41e5-b18b-09b2071a7d93","topicName":"Chlamydia - uncomplicated genital","slug":"chlamydia-uncomplicated-genital","lastRevised":"Last revised in January 2021","chapters":[{"id":"0b0636d2-117b-5108-b70c-d19a794db377","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"dda664e4-4864-5386-8bf2-ae38fe324071","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"6af905a1-8c41-53d9-b5ca-e96a0b2548be","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"84014645-1e22-51ca-b89b-52cd820d41b7","slug":"changes","fullItemName":"Changes"},{"id":"66fb5a16-c4f5-562e-9a73-84371e2bbe0d","slug":"update","fullItemName":"Update"}]},{"id":"82517c94-8e8a-5c62-b7d6-670ad4404258","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"0f150da5-1397-5e5d-b3dd-c9f2716423aa","slug":"goals","fullItemName":"Goals"},{"id":"f52e0aef-b3ad-5e13-b9ed-d426b4fa2f77","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"ba38cbe0-ef08-5c56-a1f4-9a962b32ad9f","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"2ced83fa-49d9-5243-8a7f-d942baa4bc1f","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"5887995c-3455-537d-98cc-b1aeb54144ed","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"c0f2bffb-9529-57db-a995-191cba2d4e9f","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"824044f0-a305-5a18-9a1d-bf36875a6ce8","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"5b8da5a2-6086-58db-9ad4-94fe2eb8bd48","slug":"definition","fullItemName":"Definition"},{"id":"ae31b546-618f-5b61-bf90-254c4868b504","slug":"prevalence","fullItemName":"Prevalence"},{"id":"8cd27f8c-d2f1-57ac-83e8-ed035b78ee51","slug":"risk-factors","fullItemName":"Risk Factors"},{"id":"ab8dc958-d4dc-5fef-ac7c-bc2b5865fdbe","slug":"prognosis-complications","fullItemName":"Prognosis and complications"}]},{"id":"3a69be68-2fd6-509b-85f4-164afc701ba8","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"a927a8de-387f-5d99-8924-b8836a37e1a0","slug":"screening-for-chlamydia-in-asymptomatic-men-women","fullItemName":"Screening for chlamydia in asymptomatic men and women"},{"id":"9da777e0-887a-5bb6-af7a-f6f0b986dbf4","slug":"signs-symptoms","fullItemName":"Signs and symptoms"},{"id":"0a0b5d7a-0455-5688-90d5-253f427816b6","slug":"testing-to-confirm-the-diagnosis","fullItemName":"Testing to confirm the diagnosis"}]},{"id":"366e3be0-ac7e-5c90-baed-b3485d6e47ae","fullItemName":"Management","slug":"management","subChapters":[{"id":"9b3c090d-c63e-54c5-8cd1-1f401bc12c7b","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"e1354798-4643-56ab-8360-3c7075ebaa79","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"0cd2f484-1947-55ec-980e-1d0293ab355e","slug":"amoxicillin","fullItemName":"Amoxicillin"},{"id":"48da76f5-5041-504f-ab81-69b4fe7ff549","slug":"azithromycin","fullItemName":"Azithromycin"},{"id":"f100927d-5a5a-5112-bec9-59e5e4d4f040","slug":"doxycycline","fullItemName":"Doxycycline"},{"id":"07eef3f6-7862-5fc9-b60f-ffa9d201996a","slug":"erythromycin","fullItemName":"Erythromycin"},{"id":"dacb6886-00ac-5160-9ee9-3ec19959d6ee","slug":"ofloxacin","fullItemName":"Ofloxacin"}]},{"id":"41a663fd-74e7-5b4b-b936-d4894268ff1f","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"34dd7d77-0b55-5661-b769-73e6cade3309","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"ffbef724-e30a-592a-836b-c4c5163d2e15","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"0964fb39-dd03-54bb-af48-c376a46d685b","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"d69f8f7d-515f-5861-85b0-f5d6cf0ecfac","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"2c32cb59-e5a3-5af2-b976-e11d73a2ea8a","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"87f9e401-f03f-547f-a524-e2f66bfb58c0","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"69fd8a3f-633f-5092-85dd-f2220728872d","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"3a69be68-2fd6-509b-85f4-164afc701ba8","slug":"diagnosis","fullItemName":"Diagnosis"},"subChapters":[{"id":"534d6b1d-5a54-557b-975f-02c1bdefd0ca","slug":"basis-for-recommendation-6ce","fullItemName":"Basis for recommendation","depth":3,"htmlHeader":"<!-- begin field ddd29741-22d4-461c-8921-b283773fdf32 --><h3>Basis for recommendation</h3><!-- end field ddd29741-22d4-461c-8921-b283773fdf32 -->","summary":null,"htmlStringContent":"<!-- begin item 6ce43728-d112-4dbd-9f0b-f161ec925a2e --><!-- begin field 7e09f68d-e685-42e1-91cc-43f6b1cc9b40 --><p>The recommendations on when to suspect chlamydia infection and testing to confirm the diagnosis are based on expert opinion in the British Association for Sexual Health and HIV (BASHH) <em>2015 UK national guideline for the management of infection with Chlamydia trachomatis</em>, [<a class=\"bibliography-reference internal-reference\" href=\"/topics/chlamydia-uncomplicated-genital/references/\">BASHH, 2015</a>] and the Scottish Intercollegiate Guidelines Network (SIGN) guideline <em>Management of genital Chlamydia trachomatis infection </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/chlamydia-uncomplicated-genital/references/\">SIGN, 2009</a>]<em>.</em></p><!-- end field 7e09f68d-e685-42e1-91cc-43f6b1cc9b40 --><!-- end item 6ce43728-d112-4dbd-9f0b-f161ec925a2e -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}